Michael Dabrowski
CEO
Pelago Bioscience
Sweden
Biography
Michael has 15 years of Drug Discovery experience from Novo Nordisk and AstraZeneca in multiple therapeutic areas and a strong track delivery record of science, project, people and budget management. Michael has vast experience as a project leader, manager responsible for screening and assay technology development as well as strategic disease area portfolio management and execution.
Research Interest
Michael has vast experience as a project leader, manager responsible for screening and assay technology development
